All posts tagged: Wirecopy

Erik ten Hag labels reaction to Manchester United’s Coventry win ’embarrassing’ and a ‘disgrace’

Erik ten Hag labels reaction to Manchester United’s Coventry win ’embarrassing’ and a ‘disgrace’

[ad_1] Ten Hag admitted Antony should not have acted in such fashion but revealed that his behaviour was a reaction to early provocation from Coventry players. “Did you see the reaction of Harry Maguire?” Ten Hag asked. “He [Antony] was provoked. This was a reaction to that. You haven’t seen the provocation, you only saw the reaction. But he should not do it. “But I have also seen Harry Maguire straight after and others. We should acknowledge the performance from Coventry to come into that final and come back. We are for 70 minutes totally dominating the game by far and creating many chances and 3-0 must have been the game closed. But the return from their side was very good.” United play bottom club Sheffield United at Old Trafford on Wednesday night when Ten Hag could be without at least 12 senior players after his squad was further decimated by injuries sustained against Coventry. Ten Hag has doubts over Scott McTominay and Marcus Rashford and hopes Alejandro Garnacho and Bruno Fernandes can recover from …

New cancer drug could improve prognosis for Covid patients

New cancer drug could improve prognosis for Covid patients

[ad_1] A new cancer drug could improve the prognosis for patients whose lungs have been severely damaged by Covid. Scientists from Anglia Ruskin University (ARU) have discovered that a new type of cell therapy called agenT-797 could be beneficial for those with acute respiratory disease syndrome (ARDS). ARDS is a life-threatening disease which occurs when a person’s lungs are not working properly – and has been observed in those who suffered a serious Covid-19 infection. While agenT-797 is primarily being developed to treat people with cancer, the research team at ARU decided to investigate its uses for other illnesses. They carried out trials on 20 mechanically-ventilated patients who were suffering with severe ARDS as a result of Covid-19, and found that agenT-797 prompted an anti-inflammatory response – potentially encouraging the patient’s immune system to fight infection. Of the patients in the trial, 70 per cent survived at 30 days – compared to a control group of 10 per cent. Those who received the highest dosage of agenT-797 were also 80 per cent less likely to …